Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Vertex Pharmaceuticals ( VRTX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.2%. By the end of trading, Vertex Pharmaceuticals fell $1.51 (-1.9%) to $79.81 on light volume. Throughout the day, 950,225 shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 1,485,800 shares. The stock ranged in price between $79.26-$81.50 after having opened the day at $81.37 as compared to the previous trading day's close of $81.32. Other companies within the Health Care sector that declined today were: NanoString Technologies ( NSTG), down 15.4%, AVANIR Pharmaceuticals ( AVNR), down 13.4%, Idenix Pharmaceuticals ( IDIX), down 7.9% and ProPhase Labs ( PRPH), down 7.0%.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Vertex Pharmaceuticals has a market cap of $19.1 billion and is part of the drugs industry. Shares are up 94.1% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Vertex Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, GW Pharmaceuticals PLC ADR ( GWPH), up 47.7%, Aoxing Pharmaceutical Company ( AXN), up 31.8%, Galectin Therapeutics ( GALT), up 26.6% and GTx ( GTXI), up 21.4% , were all gainers within the health care sector with WellPoint ( WLP) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home